Analyst Just Declared Lilly the Clear Winner at ADA Conference
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesThe ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Conagra (CAG) faces a pivotal year as 2026 earnings hinge on pricing, cost control, and portfolio focus. This analysi...
When a feud becomes a marketing engine, money talks louder than records. This feature examines how T.I. targets Cent ...
If you have $1,000 and want a crypto with staying power, this guide explains why Ethereum often fits the bill for lon...
A Goldman Sachs analysis argues the Iran conflict will lift energy prices but is unlikely to trigger a broad global s...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
Amazon's liquidity position is tightening as it pours billions into AI infrastructure. Investors pore over cash metri...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
As Target prepares for its Q1 2026 earnings call, savvy investors want clarity on sales growth, margins, and the path...
Mercadolibre stock down strong after a mixed reaction to solid quarterly results. This article breaks down why growth...
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...